THE RELATIONSHIP OF GLP1R PATHWAY GENES TO CAR DIOVASCULAR DISEASE AND MAJOR DEPRESSION

被引：0
|
作者：
Cox, Nancy [1 ]
Shuey, Megan [1 ]
Singh, Kritika [2 ]
Miller-Fleming, Tyne [1 ]
Davis, Lea K. [1 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] Vanderbilt Univ, Med Ctr, Vanderbilt Genet Inst, Nashville, TN USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2022年 / 63卷
关键词：
D O I：
10.1016/j.euroneuro.2022.07.044
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E18 / E18
页数：1
相关论文
共 50 条
  • [21] GLP1R Agonists and Precision Medicine: In Search of Predictive Biomarkers
    Bagheri, Sayna
    Pilla, Scott J.
    Taylor, Simeon, I
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 110 (04): : e1272 - e1273
  • [22] GLP1R Regualtion of Gap Junction Coupling in the Islet of Langerhans
    Walter, Rachelle
    Farnsworth, Nikki
    Benninger, Richard
    FASEB JOURNAL, 2015, 29
  • [23] GLP1R agonists: primary cardiovascular prevention and oral administration
    Lim, Gregory B.
    NATURE REVIEWS CARDIOLOGY, 2019, 16 (08) : 453 - 453
  • [24] The Hypothalamic Glucagon-like Peptide-1 (Glp1) Receptor (Glp1r) Is Necessary for the Anorectic Effects of Endogenous Glp1 but Not of the Glp1r Agonist Exendin-4 (Ex4)
    Burmeister, Melissa A.
    Smouse, Hannah
    Landivar-Rocha, Adriana
    Ayala, Jennifer E.
    Stoffers, Doris A.
    Seeley, Randy J.
    Ayala, Julio E.
    DIABETES, 2014, 63 : A99 - A100
  • [25] GLP1R agonists: primary cardiovascular prevention and oral administration
    Gregory B. Lim
    Nature Reviews Cardiology, 2019, 16 : 453 - 453
  • [26] Genetic approach supports cardiovascular safety of GLP1R agonists
    Irene Fernández-Ruiz
    Nature Reviews Cardiology, 2016, 13 (8) : 444 - 444
  • [27] Contribution of SNV GLP1R in Diseasome of Metabolically Unhealthy Obesity
    Abaturov, Aleksandr
    Nikulina, Anna
    Nikulin, Dmytro
    Holikova, Anastasiia
    Dikhtyarenko, Daryna
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 153
  • [28] DIFFERENTIAL IMPACTS OF GLP1R GENE VARIANTS ON DISEASE RISK AND TREATMENT EFFICACY IN AFRICAN AMERICANS
    Scorletti, Eleonora
    Huang, Helen
    Zhang, David
    Vujkovic, Marijana
    Park, Joseph
    Kahles, Florian
    Sirugo, Giorgio
    Phillips, Michael
    Schneider, Kai Markus
    FitzGerald, Garret
    Rader, Daniel
    Schneider, Carolin
    HEPATOLOGY, 2024, 80 : S632 - S633
  • [29] Brexpiprazole caused glycolipid metabolic disorder by inhibiting GLP1/GLP1R signaling in rats
    Li, De-juan
    Yue, Qin
    Liu, Lu
    Che, Ke-ke
    Liu, Xue-mei
    Hu, Chang-hua
    ACTA PHARMACOLOGICA SINICA, 2021, 42 (08) : 1267 - 1279
  • [30] Brexpiprazole caused glycolipid metabolic disorder by inhibiting GLP1/GLP1R signaling in rats
    De-juan Li
    Qin Yue
    Lu Liu
    Ke-ke Che
    Xue-mei Liu
    Chang-hua Hu
    Acta Pharmacologica Sinica, 2021, 42 : 1267 - 1279
12345